A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.
Epistemonikos ID: 9bfd3892ca8303b3a0aef250b35a53632ebe2c46
First added on: Apr 15, 2026